Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.

Wang Y, Cheon DJ, Lu Z, Cunningham SL, Chen CM, Luo RZ, Xing D, Orsulic S, Bast RC Jr, Behringer RR.

Differentiation. 2008 Dec;76(10):1081-92. doi: 10.1111/j.1432-0436.2008.00295.x. Epub 2008 Jul 2.

2.

MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope.

Argüeso P, Spurr-Michaud S, Russo CL, Tisdale A, Gipson IK.

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2487-95.

PMID:
12766047
3.
4.

Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.

Rao TD, Tian H, Ma X, Yan X, Thapi S, Schultz N, Rosales N, Monette S, Wang A, Hyman DM, Levine DA, Solit D, Spriggs DR.

PLoS One. 2015 May 12;10(5):e0126633. doi: 10.1371/journal.pone.0126633. eCollection 2015.

5.

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.

Comamala M, Pinard M, Thériault C, Matte I, Albert A, Boivin M, Beaudin J, Piché A, Rancourt C.

Br J Cancer. 2011 Mar 15;104(6):989-99. doi: 10.1038/bjc.2011.34. Epub 2011 Feb 15.

6.

Human kallikrein related peptidases 6 and 13 in combination withCA125 is a more sensitive test for ovarian cancer than CA125 alone.

White NM, Mathews M, Yousef GM, Prizada A, Fontaine D, Ghatage P, Popadiuk C, Dawson L, Doré JJ.

Cancer Biomark. 2009;5(6):279-87. doi: 10.3233/CBM-2009-0113.

PMID:
20037204
7.

Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.

Akita K, Yoshida S, Ikehara Y, Shirakawa S, Toda M, Inoue M, Kitawaki J, Nakanishi H, Narimatsu H, Nakada H.

Int J Gynecol Cancer. 2012 May;22(4):531-8. doi: 10.1097/IGC.0b013e3182473292.

PMID:
22367369
8.

Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.

Yin BW, Dnistrian A, Lloyd KO.

Int J Cancer. 2002 Apr 10;98(5):737-40.

9.

Differential expression of MUC16 in human oral mucosal epithelium and cultivated epithelial sheets.

Hori Y, Nishida K, Yamato M, Sugiyama H, Soma T, Inoue T, Maeda N, Okano T, Tano Y.

Exp Eye Res. 2008 Sep;87(3):191-6. doi: 10.1016/j.exer.2008.05.014. Epub 2008 Jul 21.

PMID:
18644592
10.

Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).

Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM, Moniaux N, Batra SK.

Mod Pathol. 2006 Oct;19(10):1386-94. Epub 2006 Jul 28.

11.

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.

Gubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, Bera TK, Connor J, Sathyanarayana BK, Lee B, Pastan I, Patankar MS.

Mol Cancer. 2006 Oct 26;5(1):50.

12.
13.

Pathobiological implications of MUC16 expression in pancreatic cancer.

Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK.

PLoS One. 2011;6(10):e26839. doi: 10.1371/journal.pone.0026839. Epub 2011 Oct 31.

14.

CA125/MUC16 is dispensable for mouse development and reproduction.

Cheon DJ, Wang Y, Deng JM, Lu Z, Xiao L, Chen CM, Bast RC, Behringer RR.

PLoS One. 2009;4(3):e4675. doi: 10.1371/journal.pone.0004675. Epub 2009 Mar 5.

15.

Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.

Garg G, Gibbs J, Belt B, Powell MA, Mutch DG, Goedegebuure P, Collins L, Piwnica-Worms D, Hawkins WG, Spitzer D.

BMC Cancer. 2014 Jan 21;14:35. doi: 10.1186/1471-2407-14-35.

16.

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Felder M, Kapur A, Gonzalez-Bosquet J, Horibata S, Heintz J, Albrecht R, Fass L, Kaur J, Hu K, Shojaei H, Whelan RJ, Patankar MS.

Mol Cancer. 2014 May 29;13:129. doi: 10.1186/1476-4598-13-129. Review.

17.

Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents.

Rao TD, Rosales N, Spriggs DR.

Mol Cancer Ther. 2011 Oct;10(10):1939-48. doi: 10.1158/1535-7163.MCT-11-0228. Epub 2011 Aug 4.

18.

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.

Rump A, Morikawa Y, Tanaka M, Minami S, Umesaki N, Takeuchi M, Miyajima A.

J Biol Chem. 2004 Mar 5;279(10):9190-8. Epub 2003 Dec 15.

19.

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival.

Williams KA, Terry KL, Tworoger SS, Vitonis AF, Titus LJ, Cramer DW.

PLoS One. 2014 Feb 13;9(2):e88334. doi: 10.1371/journal.pone.0088334. eCollection 2014.

20.

A binding domain on mesothelin for CA125/MUC16.

Kaneko O, Gong L, Zhang J, Hansen JK, Hassan R, Lee B, Ho M.

J Biol Chem. 2009 Feb 6;284(6):3739-49. doi: 10.1074/jbc.M806776200. Epub 2008 Dec 15.

Supplemental Content

Support Center